Logo image of 1CROX.MI

CROCS INC (1CROX.MI) Stock Fundamental Analysis

BIT:1CROX - US2270461096 - Common Stock

75.12 EUR
+2.32 (+3.19%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to 1CROX. 1CROX was compared to 46 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the health and profitability get an excellent rating, making 1CROX a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on 1CROX. These ratings could make 1CROX a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

1CROX had positive earnings in the past year.
In the past year 1CROX had a positive cash flow from operations.
In the past 5 years 1CROX has always been profitable.
Each year in the past 5 years 1CROX had a positive operating cash flow.
1CROX.MI Yearly Net Income VS EBIT VS OCF VS FCF1CROX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

With a Return On Assets value of 5.31%, 1CROX perfoms like the industry average, outperforming 54.35% of the companies in the same industry.
Looking at the Return On Equity, with a value of 16.64%, 1CROX is in line with its industry, outperforming 56.52% of the companies in the same industry.
1CROX has a Return On Invested Capital of 20.14%. This is amongst the best in the industry. 1CROX outperforms 89.13% of its industry peers.
1CROX had an Average Return On Invested Capital over the past 3 years of 18.73%. This is significantly above the industry average of 11.06%.
The 3 year average ROIC (18.73%) for 1CROX is below the current ROIC(20.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.31%
ROE 16.64%
ROIC 20.14%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)18.73%
ROIC(5y)24.73%
1CROX.MI Yearly ROA, ROE, ROIC1CROX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

The Profit Margin of 1CROX (5.72%) is comparable to the rest of the industry.
1CROX's Profit Margin has improved in the last couple of years.
1CROX has a better Operating Margin (24.24%) than 91.30% of its industry peers.
In the last couple of years the Operating Margin of 1CROX has grown nicely.
The Gross Margin of 1CROX (59.36%) is comparable to the rest of the industry.
1CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.24%
PM (TTM) 5.72%
GM 59.36%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
1CROX.MI Yearly Profit, Operating, Gross Margins1CROX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1CROX is creating value.
Compared to 1 year ago, 1CROX has less shares outstanding
Compared to 5 years ago, 1CROX has less shares outstanding
The debt/assets ratio for 1CROX has been reduced compared to a year ago.
1CROX.MI Yearly Shares Outstanding1CROX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
1CROX.MI Yearly Total Debt VS Total Assets1CROX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

1CROX has an Altman-Z score of 3.75. This indicates that 1CROX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of 1CROX (3.75) is better than 71.74% of its industry peers.
The Debt to FCF ratio of 1CROX is 1.79, which is an excellent value as it means it would take 1CROX, only 1.79 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1CROX (1.79) is better than 82.61% of its industry peers.
A Debt/Equity ratio of 0.97 indicates that 1CROX is somewhat dependend on debt financing.
1CROX's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. 1CROX is outperformed by 67.39% of its industry peers.
Although 1CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.79
Altman-Z 3.75
ROIC/WACC1.99
WACC10.13%
1CROX.MI Yearly LT Debt VS Equity VS FCF1CROX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

1CROX has a Current Ratio of 1.54. This is a normal value and indicates that 1CROX is financially healthy and should not expect problems in meeting its short term obligations.
1CROX's Current ratio of 1.54 is in line compared to the rest of the industry. 1CROX outperforms 58.70% of its industry peers.
A Quick Ratio of 0.97 indicates that 1CROX may have some problems paying its short term obligations.
With a Quick ratio value of 0.97, 1CROX perfoms like the industry average, outperforming 58.70% of the companies in the same industry.
The current and quick ratio evaluation for 1CROX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.97
1CROX.MI Yearly Current Assets VS Current Liabilites1CROX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

1CROX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.81%.
Measured over the past years, 1CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.64% on average per year.
1CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 2.04%.
Measured over the past years, 1CROX shows a very strong growth in Revenue. The Revenue has been growing by 27.23% on average per year.
EPS 1Y (TTM)3.81%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%5.49%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.41%

3.2 Future

The Earnings Per Share is expected to grow by 3.74% on average over the next years.
The Revenue is expected to grow by 3.08% on average over the next years.
EPS Next Y-8.29%
EPS Next 2Y-3.97%
EPS Next 3Y-4.15%
EPS Next 5Y3.74%
Revenue Next Year-1.59%
Revenue Next 2Y-0.45%
Revenue Next 3Y-0.08%
Revenue Next 5Y3.08%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1CROX.MI Yearly Revenue VS Estimates1CROX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
1CROX.MI Yearly EPS VS Estimates1CROX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.60 indicates a rather cheap valuation of 1CROX.
Based on the Price/Earnings ratio, 1CROX is valued cheaper than 95.65% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.02. 1CROX is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 7.27, which indicates a rather cheap valuation of 1CROX.
Based on the Price/Forward Earnings ratio, 1CROX is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.66, 1CROX is valued rather cheaply.
Industry RankSector Rank
PE 6.6
Fwd PE 7.27
1CROX.MI Price Earnings VS Forward Price Earnings1CROX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1CROX is valued cheaper than 80.43% of the companies in the same industry.
1CROX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1CROX is cheaper than 76.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.26
EV/EBITDA 5.56
1CROX.MI Per share data1CROX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The excellent profitability rating of 1CROX may justify a higher PE ratio.
1CROX's earnings are expected to decrease with -4.15% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2Y-3.97%
EPS Next 3Y-4.15%

0

5. Dividend

5.1 Amount

1CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

BIT:1CROX (9/4/2025, 7:00:00 PM)

75.12

+2.32 (+3.19%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)10-27 2025-10-27/amc
Inst Owners101.38%
Inst Owner ChangeN/A
Ins Owners2.52%
Ins Owner ChangeN/A
Market Cap4.10B
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.97%
Min EPS beat(2)3.5%
Max EPS beat(2)18.44%
EPS beat(4)4
Avg EPS beat(4)11.28%
Min EPS beat(4)3.5%
Max EPS beat(4)18.44%
EPS beat(8)8
Avg EPS beat(8)12.22%
EPS beat(12)12
Avg EPS beat(12)13.45%
EPS beat(16)16
Avg EPS beat(16)15.25%
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)0.03%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.22%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)6
Avg Revenue beat(12)0.35%
Revenue beat(16)9
Avg Revenue beat(16)0.5%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-28.16%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-7.98%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-10.63%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.72%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.6
Fwd PE 7.27
P/S 1.16
P/FCF 6.26
P/OCF 5.75
P/B 3.39
P/tB N/A
EV/EBITDA 5.56
EPS(TTM)11.38
EY15.15%
EPS(NY)10.34
Fwd EY13.76%
FCF(TTM)12
FCFY15.98%
OCF(TTM)13.07
OCFY17.4%
SpS64.61
BVpS22.19
TBVpS-4.98
PEG (NY)N/A
PEG (5Y)0.13
Profitability
Industry RankSector Rank
ROA 5.31%
ROE 16.64%
ROCE 26.86%
ROIC 20.14%
ROICexc 21.29%
ROICexgc 41.92%
OM 24.24%
PM (TTM) 5.72%
GM 59.36%
FCFM 18.58%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)18.73%
ROIC(5y)24.73%
ROICexc(3y)19.58%
ROICexc(5y)28.15%
ROICexgc(3y)57.87%
ROICexgc(5y)51.82%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score8
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.79
Debt/EBITDA 1.28
Cap/Depr 92.37%
Cap/Sales 1.65%
Interest Coverage 11.92
Cash Conversion 77.72%
Profit Quality 325.08%
Current Ratio 1.54
Quick Ratio 0.97
Altman-Z 3.75
F-Score8
WACC10.13%
ROIC/WACC1.99
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.81%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%5.49%
EPS Next Y-8.29%
EPS Next 2Y-3.97%
EPS Next 3Y-4.15%
EPS Next 5Y3.74%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.41%
Revenue Next Year-1.59%
Revenue Next 2Y-0.45%
Revenue Next 3Y-0.08%
Revenue Next 5Y3.08%
EBIT growth 1Y-6.14%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-1.52%
EBIT Next 3Y-1.8%
EBIT Next 5Y4.44%
FCF growth 1Y3.44%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y-1.37%
OCF growth 3Y20.5%
OCF growth 5Y61.62%